AAAAAA
Results: 1-25/42
Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results ofa placebo controlled study
Authors:
Nyirjesy, P
Sobel, JD
Weitz, MV
Leaman, DJ
Small, MJ
Gelone, SP
Citation: P. Nyirjesy et al., Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results ofa placebo controlled study, SEX TRANS I, 77(1), 2001, pp. 53-57
Authors:
Vazquez, JA
Peng, G
Sobel, JD
Steele-Moore, L
Schuman, P
Holloway, W
Neaton, JD
Citation: Ja. Vazquez et al., Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis, CLIN INF D, 33(7), 2001, pp. 1069-1075
Authors:
Sobel, JD
Rex, JH
Citation: Jd. Sobel et Jh. Rex, Invasive candidiasis: Turning risk into a practical prevention policy?, CLIN INF D, 33(2), 2001, pp. 187-190
Authors:
Rex, JH
Walsh, TJ
Nettleman, M
Anaissie, EJ
Bennett, JE
Bow, EJ
Carillo-Munoz, AJ
Chavanet, P
Cloud, GA
Denning, DW
de Pauw, BE
Edwards, JE
Hiemenz, JW
Kauffman, CA
Lopez-Berestein, G
Martino, P
Sobel, JD
Stevens, DA
Sylvester, R
Tollemar, J
Viscoli, C
Viviani, MA
Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Authors:
Rex, JH
Sobel, JD
Citation: Jh. Rex et Jd. Sobel, Prophylactic antifungal therapy in the intensive care unit, CLIN INF D, 32(8), 2001, pp. 1191-1200
Authors:
Rex, JH
Walsh, TJ
Sobel, JD
Filler, SG
Pappas, PG
Dismukes, WE
Edwards, JE
Citation: Jh. Rex et al., Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32 : 320-1) and Drs. Marrand Boeckh (Clin Infect Dis 2001; 32 : 321), CLIN INF D, 32(3), 2001, pp. 518-519
Authors:
Ormerod, LD
Puklin, JE
Sobel, JD
Citation: Ld. Ormerod et al., Syphilitic posterior uveitis: Correlative findings and significance, CLIN INF D, 32(12), 2001, pp. 1661-1673
Authors:
Foxman, B
Somsel, P
Tallman, P
Gillespie, B
Raz, R
Colodner, R
Kandula, D
Sobel, JD
Citation: B. Foxman et al., Urinary tract infection among women aged 40 to 65: Behavioral and sexual risk factors, J CLIN EPID, 54(7), 2001, pp. 710-718
Authors:
Barousse, MM
Steele, C
Dunlap, K
Espinosa, T
Boikov, D
Sobel, JD
Fidel, PL
Citation: Mm. Barousse et al., Growth inhibition of Candida albicans by human vaginal epithelial cells, J INFEC DIS, 184(11), 2001, pp. 1489-1493
Authors:
Leigh, JE
Barousse, M
Swoboda, RK
Myers, T
Hager, S
Wolf, NA
Cutright, JL
Thompson, J
Sobel, JD
Fidel, PL
Citation: Je. Leigh et al., Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis, J INFEC DIS, 183(2), 2001, pp. 277-285
Authors:
Sobel, JD
Ohmit, SE
Schuman, P
Klein, RS
Mayer, K
Duerr, A
Vazquez, JA
Rompalo, A
Citation: Jd. Sobel et al., The evolution of Candida species and fluconazole susceptibility among oraland vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women, J INFEC DIS, 183(2), 2001, pp. 286-293
Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole
Authors:
Sobel, JD
Kapernick, PS
Zervos, M
Reed, BD
Hooton, T
Soper, D
Nyirjesy, P
Heine, MW
Willems, J
Panzer, H
Wittes, H
Citation: Jd. Sobel et al., Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole, AM J OBST G, 185(2), 2001, pp. 363-369
Authors:
Tiraboschi, IN
Bennett, JE
Kauffman, CA
Rex, JH
Girmenia, C
Sobel, JD
Menichetti, F
Citation: In. Tiraboschi et al., Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium, MED MYCOL, 38, 2000, pp. 199-204
Authors:
Sobel, JD
Citation: Jd. Sobel, Gynecologic infections in human immunodeficiency virus-infected women, CLIN INF D, 31(5), 2000, pp. 1225-1233
Authors:
Sobel, JD
Citation: Jd. Sobel, Practice guidelines for the treatment of fungal infections, CLIN INF D, 30(4), 2000, pp. 652-652
Authors:
Rex, JH
Walsh, TJ
Sobel, JD
Filler, SG
Pappas, PG
Dismukes, WE
Edwards, JE
Citation: Jh. Rex et al., Practice guidelines for the treatment of candidiasis, CLIN INF D, 30(4), 2000, pp. 662-678
Authors:
Saag, MS
Graybill, RJ
Larsen, RA
Pappas, PG
Perfect, JR
Powderly, WG
Sobel, JD
Dismukes, WE
Citation: Ms. Saag et al., Practice guidelines for the management of cryptococcal disease, CLIN INF D, 30(4), 2000, pp. 710-718
Authors:
Kauffman, CA
Vazquez, JA
Sobel, JD
Gallis, HA
McKinsey, DS
Karchmer, AW
Sugar, AM
Sharkey, PK
Wise, GJ
Mangi, R
Mosher, A
Lee, JY
Dismukes, WE
Citation: Ca. Kauffman et al., Prospective multicenter surveillance study of funguria in hospitalized patients, CLIN INF D, 30(1), 2000, pp. 14-18
Authors:
Sobel, JD
Kauffman, CA
McKinsey, D
Zervos, M
Vazquez, JA
Karchmer, AW
Lee, J
Thomas, C
Panzer, H
Dismukes, WE
Citation: Jd. Sobel et al., Candiduria: A randomized, double-blind study of treatment with fluconazoleand placebo, CLIN INF D, 30(1), 2000, pp. 19-24
Authors:
Foxman, B
Barlow, R
D'Arcy, H
Gillespie, B
Sobel, JD
Citation: B. Foxman et al., Urinary tract infection: Self reported incidence and associated costs, ANN EPIDEMI, 10(8), 2000, pp. 509-515
Authors:
Ben-Josef, AM
Manavathu, EK
Platt, D
Sobel, JD
Citation: Am. Ben-josef et al., Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296, INT J ANT A, 13(4), 2000, pp. 287-295
Authors:
Lundstrom, TS
Sobel, JD
Citation: Ts. Lundstrom et Jd. Sobel, Antibiotics for gram-positive bacterial infections - Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid, INF DIS CL, 14(2), 2000, pp. 463
Authors:
Foxman, B
Barlow, R
D'Arcy, H
Gillespie, B
Sobel, JD
Citation: B. Foxman et al., Candida vaginitis - Self-reported incidence and associated costs, SEX TRA DIS, 27(4), 2000, pp. 230-235
Authors:
Sobel, JD
Citation: Jd. Sobel, Use of antifungal drugs in pregnancy - A focus on safety, DRUG SAFETY, 23(1), 2000, pp. 77-85
Authors:
Sobel, JD
Citation: Jd. Sobel, Bacterial vaginosis, ANN R MED, 51, 2000, pp. 349-356